Additionally, cardiac glycosides, inhibitors of the sodium-potassium ATPase, have been shown to enhance autophagy in gastric cancer cells by reducing the expression of glucose transporter 1 (GLUT1) (Fujii et al., 2022). The gene discussed is SLC2A1; the disease is gastric cancer.